• Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Single User
Provide PDF Format

Learn More

Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Single User

  • Customers Who Bought This Also Bought
  • Report / Survey by Thomson Reuters BioWorld, 09/30/2014
  • Publisher: BioWorld

$1,998.00$3,995.00


  • Interactive PDF of data, projections, and analysis
  • >100 deals involving follow-on biologics (FOBs) identified
  • 700 biosimilars and 245 companies profiled
  • Updates on approvals and pipeline developments
  • Analysis of competitive landscape, defensive strategies, and market share
  • Market/regulatory analysis of 25 countries in Europe, Asia/Pacific, Latin America, Middle East, Africa, and North America
  • Core drivers and IP issues impacting biosimilar growth
  • and much more

Enterprise version also available.

Related Products